Transcription factor EB activation rescues advanced αB-crystallin mutation-induced cardiomyopathy by normalizing desmin localization

Xiucui Ma, Kartik Mani, Haiyan Liu, Attila Kovacs, John T. Murphy, Layla Foroughi, Brent A. French, Carla J. Weinheimer, Aldi Kraja, Ivor J. Benjamin, Joseph A. Hill, Ali Javaheri, Abhinav Diwan

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Background—Mutations in αB-crystallin result in proteotoxic cardiomyopathy with desmin mislocalization to protein aggregates. Intermittent fasting (IF) is a novel approach to activate transcription factor EB (TFEB), a master regulator of the autophagylysosomal pathway, in the myocardium. We tested whether TFEB activation can be harnessed to treat advanced proteotoxic cardiomyopathy. Methods and Results—Mice overexpressing the R120G mutant of αB-crystallin in cardiomyocytes (Myh6-CryABR120G) were subjected to IF or ad-lib feeding, or transduced with adeno-associated virus–TFEB or adeno-associated virus—green fluorescent protein after development of advanced proteotoxic cardiomyopathy. Adeno-associated virus–short hairpin RNA–mediated knockdown of TFEB and HSPB8 was performed simultaneously with IF. Myh6-CryABR120G mice demonstrated impaired autophagic flux, reduced lysosome abundance, and mammalian target of rapamycin activation in the myocardium. IF resulted in mammalian target of rapamycin inhibition and nuclear translocation of TFEB with restored lysosome abundance and autophagic flux; and reduced aggregates with normalized desmin localization. IF also attenuated left ventricular dilation and myocardial hypertrophy, increased percentage fractional shortening, and increased survival. Adeno-associated virus–TFEB transduction was sufficient to rescue cardiomyopathic manifestations, and resulted in reduced aggregates and normalized desmin localization in Myh6-CryABR120G mice. CryABR120G-expressing hearts demonstrated increased interaction of desmin with αB-crystallin and reduced interaction with chaperone protein, HSPB8, compared with wild type, which was reversed by both IF and TFEB transduction. TFEB stimulated autophagic flux to remove protein aggregates and transcriptionally upregulated HSPB8, to restore normal desmin localization in CryABR120G-expressing cardiomyocytes. Short hairpin RNA–mediated knockdown of TFEB and HSPB8 abrogated IF effects, in vivo. Conclusions—IF and TFEB activation are clinically relevant therapeutic strategies to rescue advanced R120G αB-crystallin mutantinduced cardiomyopathy by normalizing desmin localization via autophagy-dependent and autophagy-independent mechanisms.

Original languageEnglish (US)
Article numbere010866
JournalJournal of the American Heart Association
Issue number4
StatePublished - 2019


  • Cardiomyopathy
  • HspB8
  • Intermittent fasting
  • Protein aggregates
  • TFEB
  • αB-crystallin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Transcription factor EB activation rescues advanced αB-crystallin mutation-induced cardiomyopathy by normalizing desmin localization'. Together they form a unique fingerprint.

Cite this